Related Experiment Video
Updated: Jan 19, 2026
07:44
Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay
Published on: March 12, 2018
10.6K
Canadian Lung Cancer Conference 2019
Current Oncology (Toronto, Ont.)
|September 25, 2019
Summary
The 19th Canadian Lung Cancer Conference highlighted advances in lung cancer care. Key topics included immunotherapy biomarkers, oligoprogressive disease, and caregiver burnout.
Area of Science:
- Oncology
- Pulmonology
- Medical Education
Background:
- The 19th Canadian Lung Cancer Conference convened in Vancouver, BC, on February 7-8, 2019.
- This annual event serves as a vital interdisciplinary platform for Canadian healthcare professionals.
Framework:
- The conference focused on reviewing the latest scientific and clinical advancements in lung cancer management.
- Expert presentations and discussions formed the core of the educational framework.
Implementation:
- Key themes included the role of biomarkers in guiding immunotherapy decisions.
- Discussions also addressed novel approaches for managing oligoprogressive disease.
- Strategies for mitigating caregiver burnout in oncology settings were explored.
Implications:
- The conference provided critical updates for improving lung cancer patient care and outcomes.
- Sharing knowledge on emerging therapies and supportive care enhances the Canadian oncology landscape.
- Addressing caregiver burnout is essential for sustainable, high-quality cancer care delivery.
Related Concept Videos
01:47Lung Capacity
56.1K
The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
56.1K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K